FilingSEC EDGAR8-K
MetaVia to Present Phase 1 Clinical Trial Data for DA-1726 at Precision Liver Symposium 2026
· SEC accepted
StagePhase 1
Filing content
MetaVia announced that data from its Phase 1 clinical trial of DA-1726 will be presented orally at the Precision Liver Symposium 2026 on November 4, 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…